These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38874241)

  • 1. Investigation of the Status of Immune Checkpoint Molecules in Meningiomas by Immunohistochemistry.
    Saygin I; Cakir E; Kazaz SN; Guvercin AR; Eyuboglu I; Ustaoglu MM
    Turk Neurosurg; 2024; 34(4):647-654. PubMed ID: 38874241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry.
    Saygin İ; Çakir E; Kazaz SN; Güvercin AR; Eyüpoğlu İ; Ustaoğlu MM
    Turk J Med Sci; 2024; 54(4):735-743. PubMed ID: 39295608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
    Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
    J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
    Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
    J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
    Han SJ; Reis G; Kohanbash G; Shrivastav S; Magill ST; Molinaro AM; McDermott MW; Theodosopoulos PV; Aghi MK; Berger MS; Butowski NA; Barani I; Phillips JJ; Perry A; Okada H
    J Neurooncol; 2016 Dec; 130(3):543-552. PubMed ID: 27624915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Expression of Immune Checkpoints; CTLA-4, LAG3, and TIM-3 in Cancer Cells and Tumor-infiltrating Lymphocytes (TILs) in Colorectal Carcinoma.
    Abdelrahman DI; Elhasadi I; Anbaig A; Bakry A; Mandour D; Wasefy T; Yehia AM; Alorini M; Shalaby AM; Yahia AIO; Alabiad MA
    Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):71-83. PubMed ID: 38108390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.
    Fang L; Lowther DE; Meizlish ML; Anderson RC; Bruce JN; Devine L; Huttner AJ; Kleinstein SH; Lee JY; Stern JN; Yaari G; Lovato L; Cronk KM; O'Connor KC
    Neuro Oncol; 2013 Nov; 15(11):1479-90. PubMed ID: 23978377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and local immunosuppression in patients with high-grade meningiomas.
    Li YD; Veliceasa D; Lamano JB; Lamano JB; Kaur G; Biyashev D; Horbinski CM; Kruser TJ; Bloch O
    Cancer Immunol Immunother; 2019 Jun; 68(6):999-1009. PubMed ID: 31030234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival.
    Tu L; Guan R; Yang H; Zhou Y; Hong W; Ma L; Zhao G; Yu M
    Int J Cancer; 2020 Jul; 147(2):423-439. PubMed ID: 31721169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The appropriate frequency and function of decidual Tim-3
    Wang S; Sun F; Li M; Qian J; Chen C; Wang M; Zang X; Li D; Yu M; Du M
    Cell Death Dis; 2019 May; 10(6):407. PubMed ID: 31138782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data.
    Figarella-Branger D; Roche PH; Daniel L; Dufour H; Bianco N; Pellissier JF
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):113-22. PubMed ID: 9160896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
    Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CTLA-4 and Tim-3 pathways induces fetal loss with altered cytokine profiles by decidual CD4
    Wang S; Chen C; Li M; Qian J; Sun F; Li Y; Yu M; Wang M; Zang X; Zhu R; Li D; Du M
    Cell Death Dis; 2019 Jan; 10(1):15. PubMed ID: 30622243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O; Demirhan B; Altinörs N
    Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiomatous meningioma: a clinicopathologic study of 38 cases.
    Hasselblatt M; Nolte KW; Paulus W
    Am J Surg Pathol; 2004 Mar; 28(3):390-3. PubMed ID: 15104303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.
    Lee SH; Lee YS; Hong YG; Kang CS
    APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate Receptor Overexpression in Human and Canine Meningiomas-Immunohistochemistry and Case Report of Intraoperative Molecular Imaging.
    Pierce JT; Cho SS; Nag S; Zeh R; Jeon J; Holt D; Durham A; Nasrallah MP; Singhal S; Lee JYK
    Neurosurgery; 2019 Sep; 85(3):359-368. PubMed ID: 30113687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.
    Cai Z; Zhang C; Zou Y; Lu C; Hu H; Qian J; Jiang L; Hu G
    Int J Clin Oncol; 2017 Aug; 22(4):660-666. PubMed ID: 28243945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.